-
Published16/10/2024
-
Deadline20/11/2024
-
Opening of tenders20/11/2024
-
Awarded10/02/2025
-
Today04/09/2026
Utilities
Liek s účinnou látkou laronidáza, 100U/ml con inf 5ml
Liek sa používa na liečbu pacientov s ochorením MPS I (mukopolysacharidóza I). Podáva sa na liečenie neneurologických prejavov tohto ochorenia. Liek je syntetický enzým nazývaný laronidáza. Dokáže nahradiť prírodný enzým, ktorého je pri MPS I nedostatok.
https://evo.isepvo.sk/evo/Pages/Privates/ZakazkaDetail.aspx?id=517647&orgId=9183
https://evo.isepvo.sk/evo/Pages/Privates/ZakazkaDetail.aspx?id=517647&orgId=9183
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.